Skip to main content
Equibles

BARCLAYS PLC

Position in VYGR — Voyager Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to VYGR Full portfolio

Position in VYGR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$357,714
-$28,636 QoQ
Shares Held
102,204
+2.1% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 135 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. VYGR ranks #185 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in VYGR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $357,714 102,204
2026-03-31 $386,350 100,091
2025-12-31 $637,100 162,112
2025-09-30 $738,369 158,109
2025-06-30 $534,394 171,831
2025-03-31 $375,342 111,048
2024-12-31 $650,859 114,790
2024-09-30 $611,102 104,462
2024-06-30 $530,476 67,064
2024-03-31 $549,401 59,012
2023-12-31 $558,736 66,201
2023-09-30 $141,894 18,309
2023-06-30 $72,581 6,339
2023-03-31 $273,210 35,436
2022-12-31 $94,312 15,461
2022-09-30 $11,236 1,898
2021-09-30 $9,159 3,483
2021-06-30 $30,743 7,444
2021-03-31 $102,470 21,756
2020-12-31 $61,017 8,534
2020-09-30 $127,047 11,907
2020-06-30 $214,564 17,002
2020-03-31 $82,514 9,018